Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07535138) titled 'Efficacy and Safety of CD19 CAR-?d T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy' on April 6.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Air Force Military Medical University, China
Condition:
Membranous Nephropathy
Lupus Nephritis (LN)
IgA Nephropathy (IgAN)
Intervention:
Biological: CD19 CAR-?d T cell
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: May 1, 2026
Target Sample Size: 15
Countries of Recruitment:
Ch...